Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 3:16:1548522.
doi: 10.3389/fneur.2025.1548522. eCollection 2025.

Unraveling the relationship between inflammation and cluster headache

Yu-Wen Wang  1 , Xu-Hong Yang  1 , Xin-Hui Zheng  1 , Gao-Shui Zhou  1 , Xiao-Xia Zhao  1 , Yi-Lan Zhao  1 , Shu-Hong Wu  2
Affiliations
Review

Unraveling the relationship between inflammation and cluster headache

Yu-Wen Wang et al. Front Neurol. .

Abstract

Cluster headache (CH) is often referred to as the 'suicide headache.' Existing research suggests that the activation of the trigeminal-vascular system, increased sensitivity of nerve fibers, and the release and interaction of various neuropeptides and inflammatory mediators may contribute to neurogenic inflammation, which serves as a crucial pathophysiological basis for the development of CH. Additionally, some neuropeptides can modulate neuronal activity related to pain transmission and may increase pain perception by sensitizing central nerves. This review discusses the neuropeptides and inflammatory mediators associated with CH neuroinflammation, focusing on calcitonin gene-related peptide (CGRP), inflammatory cytokines and related signaling pathways, nitric oxide (NO), pituitary adenylate cyclase-activating peptide 38 (PACAP-38), and vasoactive intestinal peptide (VIP), incorporating both preclinical and clinical evidence to provide new insights into potential therapeutic targets for CH.

Keywords: cluster headache; inflammatory mediators; neurogenic inflammation; neuropeptides; trigeminal-vascular system.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Potential interactions of primary molecular mechanisms in neuroinflammation.
See this image and copyright information in PMC

References

    1. Olesen J. Headache classification Committee of the International Headache Society (Ihs) the international classification of headache disorders, 3rd Edition. Cephalalgia. (2018) 38:1–211. doi: 10.1177/0333102417738202 - DOI - PubMed
    1. Kim SA, Choi SY, Youn MS, Pozo-Rosich P, Lee MJ. Epidemiology, burden and clinical Spectrum of cluster headache: a global update. Cephalalgia. (2023) 43:43. doi: 10.1177/03331024231201577, PMID: - DOI - PubMed
    1. Negro A, Sciattella P, Spuntarelli V, Martelletti P, Mennini FS. Direct and indirect costs of cluster headache: a prospective analysis in a tertiary level headache Centre. J Headache Pain. (2020) 21:44. doi: 10.1186/s10194-020-01115-4, PMID: - DOI - PMC - PubMed
    1. Kim B-S, Chung P-W, Kim B-K, Lee MJ, Park JW, Chu MK, et al. . The impact of remission and coexisting migraine on anxiety and depression in cluster headache. J Headache Pain. (2020) 21:58. doi: 10.1186/s10194-020-01120-7, PMID: - DOI - PMC - PubMed
    1. Koo BB, Bayoumi A, Albanna A, Abusuliman M, Burrone L, Sico JJ, et al. . Demoralization predicts suicidality in patients with cluster headache. J Headache Pain. (2021) 22:28. doi: 10.1186/s10194-021-01241-7, PMID: - DOI - PMC - PubMed

LinkOut - more resources